| USWorld

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Alzheimer's drug trials to take different approach

Email Newsletters

Sign up for one of our email newsletters.

Daily Photo Galleries

By USA Today
Sunday, Oct. 7, 2012, 5:40 p.m.

Timing might be everything when it comes to treating Alzheimer's disease, according to research being presented on Monday at a meeting of the American Neurological Association in Boston.

There is no cure for the disease, which affects more than 5 million people in the country, and numbers are expected to triple by 2050.

Researchers will discuss findings on two large drug trials. Results announced last summer found that they failed to improve cognition or daily functioning compared with a placebo. The bapineuzumab and solanezumab therapies were done on patients with mild to moderate dementia. The drugs target beta amyloid, a protein in the brain believed to cause the disease.

“We think we've been starting trials too late in the progression of the disease,” said Laurie Ryan of the National Institute on Aging.

Scientists are discovering mechanisms of the disease and how it progresses. A large study in the New England Journal of Medicine found that brain changes begin as early as 25 years before the onset of symptoms.

“I'm worried that we're intervening too late and with too little” of the drugs, said Reisa Sperling of Brigham and Women's Hospital in Boston.

Subscribe today! Click here for our subscription offers.



Show commenting policy

Most-Read Nation

  1. Upstate New York town threatened by Arizona man in online post, reports say
  2. Hunt on for mother of baby buried alive in California
  3. Storm lingers in southern Plains
  4. Artists plan to rebuild Alaska art display damaged by tides
  5. Hawaii confronts dengue fever cases
  6. Police officer killed in Colorado Spring clinic rampage a co-pastor, figure skater
  7. Police union stands by Chicago officer charged with murdering teen
  8. Chicago cop charged with murder in killing of black teen
  9. Nuclear crossroad: California reactors face uncertain future
  10. Disability claim waits grow alongside swelling caseloads for judges
  11. AIDS activist finishes rowing across Atlantic